find your role first. Sign in

Raises

Reach Neuro raises $2M in November 2026 SEC filing

Reach Neuro
Raised in SEC filings
$2.2M
Filings
2
Latest est. round
Seed
Incorporated
2021
Industry
Health care
Based in
RI

Reach Neuro, a Rhode Island-based company in the Other Health Care industry, first filed with the SEC in August 2022. This filing reported a $200K sale on July 29, 2022, for an estimated pre-seed or seed round. The company was incorporated in 2021.

The company's second filing in November 2026 reported a $2M sale on October 30, 2026, for an estimated seed round. This shows an increase in the amount raised between the two rounds. Total estimated funding is $2.2M.

The latest filing names Jennifer Ernst as an executive officer and director. Thorne Sparkman, Marco Capogrosso, Douglas Weber, and Jordi Parramon are also named as directors. Find Your Role does not track open roles for Reach Neuro yet.

Every Form D filing

First saleAmount soldEst. round
2026-10-30$2MSeed
2022-07-29$200KPre-seed/Seed

Named in the latest filing

From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR

Get this in your inbox

The daily read on who's hiring and who just raised, or one email a week. Free, one click to stop.